Balance of Autonomic Nervous System Predicts Who Benefits from a Self-management Intervention Program for Irritable Bowel Syndrome
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
BACKGROUND/AIMS: To determine if potential biomarkers can be used to identify subgroups of people with irritable bowel syndrome (IBS) who will benefit the most or the least from a comprehensive self-management (CSM) intervention. METHODS: In a two-armed randomized controlled trial a CSM (n = 46) was compared to a usual care (n = 46) group with follow-up at 3 and 6 months post randomization. Biomarkers obtained at baseline included heart rate variability, salivary cortisol, interleukin-10 produced by unstimulated peripheral blood mononuclear cells, and lactulose/mannitol ratio. Linear mixed models were used to test whether these biomarkers predicted improvements in the primary outcomes including daily abdominal pain, Gastrointestinal Symptom score and IBS-specific quality of life. RESULTS: The nurse-delivered 8-session CSM intervention is more effective than usual care in reducing abdominal pain, reducing Gastrointestinal Symptom score, and enhancing quality of life. Participants with lower nighttime high frequency heart rate variability (vagal modulation) and increased low frequency/high frequency ratio (sympathovagal balance) had less benefit from CSM on abdominal pain. Salivary cortisol, IL-10, and lactulose/mannitol ratio were not statistically significant in predicting CSM benefit. Baseline symptom severity interacts with treatment, namely the benefit of CSM is greater in those with higher baseline symptoms. CONCLUSIONS: Cognitively-focused therapies may be less effective in reducing abdominal pain in IBS patients with higher sympathetic tone. Whether this a centrally-mediated patient characteristic or related to heightened arousal remains to be determined.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Only a limited number of clinical trials in IBS have evaluated associations between improvements in the disease course and changes in HRV outcomes, with conflicting results; no such trials have been conducted for IBD (67,68).”
From Alterations in Heart Rate Variability Associated With Irritable Bowel Syndrome or Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis (2021) · cites this paper as [67]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, that sample had a mean age of 41 years (intervention group) and symptom duration was not reported, which could affect ANS function in IBS patients.”
From Effects of cognitive behavior therapy on heart rate variability in young females with constipation-predominant irritable bowel syndrome: A parallel-group trial (2017) · cites this paper as [23]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Non-pharmacologic treatments, such as cognitive behavior therapy (CBT), have been effective in improving somatic symptoms of IBS.15,22,23”
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Moreover, sustained effects of CBT have not been adequately tested in IBS patients.23”
From Effects of cognitive behavior therapy on heart rate variability in young females with constipation-predominant irritable bowel syndrome: A parallel-group trial (2017) · cites this paper as [23]
Experimental — accuracy not yet measuredIn the citing paper
“In a previous study that investigated the association between baseline HRV and changes in GI symptoms after a cognitively focused behavioral intervention in patients with IBS, IBS patients with lower HF and a higher LF/HF ratio at baseline exhibited less benefit from the intervention with regard to GI symptoms than those with higher HF and lower LF/HF at baseline.23”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heart Rate Variability: Standards of Measurement, Physiological Interpretation, and Clinical Use
Electrophysiology, T. F. O. T. E. S. O. C. T. N. A. (1996) · Circulation · doi:10.1161/01.cir.93.5.1043 · Cited by 17,159
Heart rate variability: Standards of measurement, physiological interpretation, and clinical use
Malik, M., Bigger, J. T., Camm, A. J., Kleiger, R. E., Malliani, A., Moss, A. J., & Schwartz, P. J. (1996) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a014868 · Cited by 15,289
Clinical Trials: A Practical Approach.
Hill, I. D., & Pocock, S. J. (1984) · Biometrics · doi:10.2307/2531186 · Cited by 2,930 · cited 2×
“The algorithm is a modification of the minimization method proposed by Pocock.(24,25) Once the research nurse enrolled a participant and the project director entered the balancing variables, the program returned that participant’s group assignment.”
MethodPocock, S. J., & Simon, R. (1975) · Biometrics · doi:10.2307/2529712 · Cited by 2,350 · cited 2×
“The algorithm is a modification of the minimization method proposed by Pocock.(24,25) Once the research nurse enrolled a participant and the project director entered the balancing variables, the program returned that participant’s group assignment.”
MethodHeart rate variability: measurement and clinical utility.
Kleiger, R. E., Stein, P. K., & Bigger, J. T. (2005) · Annals of Noninvasive Electrocardiology · doi:10.1111/j.1542-474x.2005.10101.x · Cited by 1,290 · cited 1×
“Standard 4 hour (2-6 AM) nocturnal frequency domain HRV summary measures were computed based on power spectral analysis of R-R intervals in successive 5 minute blocks.(21,22) Low frequency (LF) band spectral power was defined as the average over 4 hours of the integration of the Fourier HRV spectra between frequencies…”
MethodUmetani, K., Singer, D. H., McCraty, R., & Atkinson, M. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00554-8 · Cited by 1,145
Piche, T., Barbara, G., Aubert, P., Bruley des Varannes, S., Dainese, R., Nano, J. L., Cremon, C., Stanghellini, V, De Giorgio, R., Galmiche, J. P., et al. (2009) · Gut · doi:10.1136/gut.2007.140806 · Cited by 540
(2006) · Cited by 534
Physical Activity Improves Symptoms in Irritable Bowel Syndrome: A Randomized Controlled Trial
Johannesson, E., Simrén, M., Strid, H., Bajor, A., & Sadik, R. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.480 · Cited by 431
Psychological treatments for irritable bowel syndrome: a systematic review and meta-analysis
Lackner, J. M., Mesmer, C., Morley, S., Dowzer, C., & Hamilton, S. (2004) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.72.6.1100 · Cited by 295
Pittig, A., Arch, J. J., Lam, C. W. R., & Craske, M. G. (2013) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2012.10.012 · Cited by 255 · cited 7×
“Higher night-time sympathovagal balance and perhaps heightened HPA activation may reflect a reduced capacity to develop and retain new strategies (relaxation, cognitive restructuring) for symptom management and as such, may signify those individuals less likely to benefit from CSM.(27) Consistent with this hypothesis…”
BackgroundInfluentialDysregulation of the hypothalamic‐pituitary‐adrenal (HPA) axis in irritable bowel syndrome
Chang, L., Sundaresh, S., Elliott, J., Anton, P. A., Baldi, P., Licudine, A., Mayer, M., Vuong, T., Hirano, M., Naliboff, B. D., et al. (2009) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2008.01171.x · Cited by 253
Self-citationClinical Trials a Practical Approach
Pocock, S. (2013) · Thammasat University Digital Collections · Cited by 211
Sensory neuro-immune interactions differ between Irritable Bowel Syndrome subtypes
Hughes, P. A., Harrington, A. M., Castro, J., Liebregts, T., Adam, B., Grasby, D. J., Isaacs, N. J., Maldeniya, L., Martin, C. M., Persson, J., et al. (2013) · Gut · doi:10.1136/gutjnl-2011-301856 · Cited by 197 · cited 1×
“IL-10 is an anti-inflammatory cytokine and contributes to the modulation of a pro-inflammatory response as well as pain sensitivity.(11,28,29) However, the role of anti-inflammatory cytokines in IBS remains controversial.”
BackgroundEvaluation of a new quality of life questionnaire for patients with irritable bowel syndrome
Hahn, B. A., Kirchdoerfer, L. J., Fullerton, S., & Mayer, E. (1997) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1997.00168.x · Cited by 185 · cited 3×
“Extensive and acceptable validity and reliability tests have been conducted for the IBSQOL.(19) A summary QOL score was computed as the average of seven of these scales, excluding the diet scale (since identifying trigger foods as part of CSM may lead to increased food avoidance) and sexual relations scale (since many…”
MethodInfluentialPsychological treatments for the management of irritable bowel syndrome
Zijdenbos, I. L., de Wit, N. J., van der Heijden, G. J., Rubin, G., & Quartero, A. O. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006442.pub2 · Cited by 180
Cytokine imbalance in irritable bowel syndrome: a systematic review and meta‐analysis
Bashashati, M., Rezaei, N., Shafieyoun, A., McKernan, D. P., Chang, L., Öhman, L., Quigley, E. M., Schmulson, M., Sharkey, K. A., & Simrén, M. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12358 · Cited by 172
Serum and Colonic Mucosal Immune Markers in Irritable Bowel Syndrome
Chang, L., Adeyemo, M., Karagiannidis, I., Videlock, E. J., Bowe, C., Shih, W., Presson, A. P., Yuan, P.-Q., Cortina, G., Gong, H., et al. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.423 · Cited by 150 · cited 1×
“These alterations include autonomic nervous system (ANS) imbalance,(3) hypothalamic-pituitary-adrenal axis (HPA) dysregulation,(4,5) increased intestinal permeability,(6,7) and immune dysregulation (ie, decreased tissue interleukin-10 [IL-10] level).(8) However, to date, no measures based on these mechanisms have prov…”
BackgroundSelf-management for women with irritable bowel syndrome
Heitkemper, M. M., Jarrett, M. E., Levy, R. L., Cain, K. C., Burr, R. L., Feld, A., Barney, P., & Weisman, P. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00242-3 · Cited by 119 · cited 3×
“The protocol for recruitment was similar to that used in 2 previously conducted RCTs.15,16 First, participants came to the research office to sign the consent form and return their completed questionnaires.”
MethodResultSelf-citationCarnevali, L., & Sgoifo, A. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00118 · Cited by 118 · cited 1×
“It has been suggested that low HRV-HF and high HRV-LF/HF ratio are indicative of an inflexible ANS, which places the individual at risk for poor health.(26,27) Higher night-time sympathovagal balance and perhaps heightened HPA activation may reflect a reduced capacity to develop and retain new strategies (relaxation,…”
BackgroundFord, A. C., Bercik, P., Morgan, D. G., Bolino, C., Pintos‐Sanchez, M. I., & Moayyedi, P. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12573 · Cited by 102 · cited 1×
“IBS is a heterogeneous condition, not only because of different bowel pattern predominance (the majority in the current study were diarrhea predominant or mixed), but also with regard to symptom severity and frequency.(31,32) An eligibility criterion for enrollment was abdominal pain/discomfort (“mild” to “severe”) at…”
BackgroundMonocytes/Macrophages Control Resolution of Transient Inflammatory Pain
Willemen, H. L. D. M., Eijkelkamp, N., Garza Carbajal, A., Wang, H., Mack, M., Zijlstra, J., Heijnen, C. J., & Kavelaars, A. (2014) · The Journal of Pain · doi:10.1016/j.jpain.2014.01.491 · Cited by 100 · cited 1×
“IL-10 is an anti-inflammatory cytokine and contributes to the modulation of a pro-inflammatory response as well as pain sensitivity.(11,28,29) However, the role of anti-inflammatory cytokines in IBS remains controversial.”
BackgroundThe Development of a Cognitive Scale for Functional Bowel Disorders
Toner, B. B., Stuckless, N., Ali, A., Downie, F., Emmott, S., & Akman, D. (1998) · Psychosomatic Medicine · doi:10.1097/00006842-199807000-00017 · Cited by 94 · cited 1×
“Cognitive scale for functional bowel disorders (CSFBD) describes 25 cognitive beliefs related to functional bowel disorders.(20) The items are rated from 1 “strongly disagree” to 7 “strongly agree,” and are summed to make a total score.”
BackgroundJarrett, M. E., Cain, K. C., Burr, R. L., Hertig, V. L., Rosen, S. N., & Heitkemper, M. M. (2009) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.479 · Cited by 89
Self-citationShulman, R. J., Jarrett, M. E., Cain, K. C., Broussard, E. K., & Heitkemper, M. M. (2014) · Journal of Gastroenterology · doi:10.1007/s00535-013-0919-6 · Cited by 86 · cited 8×
“Peripheral blood mononuclear cells (PBMCs) were isolated and incubated for 72 hours.(11) The supernatant was stored at –70C until tested for IL-10 using an ELISA assay (R&D Systems, Minneapolis, MN, USA).”
BackgroundMethodInfluentialSelf-citationRana, S., Sharma, S., Sinha, S., Parsad, K., Malik, A., & Singh, K. (2012) · Tropical Gastroenterology · doi:10.7869/tg.2012.66 · Cited by 72 · cited 1×
“Several investigators have reported reduced levels of serum anti-inflammatory cytokine IL-10(12,13) or no difference between those with IBS and controls.(14) The aim of the current study is to determine whether measures such as nighttime ANS balance, lactulose/mannitol ratio (intestinal permeability measure), and seru…”
BackgroundChemotactic Chemokines Are Important in the Pathogenesis of Irritable Bowel Syndrome
Darkoh, C., Comer, L., Zewdie, G., Harold, S., Snyder, N., & DuPont, H. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093144 · Cited by 67
Lower Serum IL-10 Is an Independent Predictor of IBS Among Volunteers in Mexico
Schmulson, M., Pulido-London, D., Rodriguez, O., Morales-Rochlin, N., Martinez-García, R., Gutierrez-Ruiz, M. C., López-Alvarenga, J. C., Robles-Díaz, G., & Gutiérrez-Reyes, G. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.484 · Cited by 64
Burr, R. L., Heitkemper, M., Jarrett, M., & Cain, K. C. (2000) · Biological Research For Nursing · doi:10.1177/109980040000200203 · Cited by 55 · cited 1×
“Indicators of ANS dysfunction, that is, low vagal tone and greater sympathetic drive, are more prevalent in individuals with IBS compared to healthy controls.(9) It is not possible to determine whether the ANS imbalance contributes directly to the pathophysiology or is the outcome of IBS (eg, result of chronic stress…”
BackgroundSelf-citationWilcz‐Villega, E., McClean, S., & O'Sullivan, M. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12262 · Cited by 53
Cheng, P., Shih, W., Alberto, M., Presson, A. P., Licudine, A., Mayer, E. A., Naliboff, B. D., & Chang, L. (2013) · Neurogastroenterology & Motility · doi:10.1111/nmo.12177 · Cited by 49
Self-citationGroup Hypnotherapy for Irritable Bowel Syndrome With Long-Term Follow-Up
Gerson, C. D., Gerson, J., & Gerson, M.-J. (2013) · International Journal of Clinical and Experimental Hypnosis · doi:10.1080/00207144.2012.700620 · Cited by 29
Heitkemper, M. M., Cain, K. C., Deechakawan, W., Poppe, A., Jun, S., Burr, R. L., & Jarrett, M. E. (2012) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2012.01915.x · Cited by 26
Self-citation
Research works printed but not linked: 1
- Barney, P, Weisman, P, Jarrett, M, Levy, R, and Heitkemper, M (2010). Master your IBS: an 8-week plan proven to control the symptoms of irritable bowel syndrome. Bethesda, MD: AGA Press, pp. 1-229.
Cited by
Intestinal Barrier Dysfunction in Irritable Bowel Syndrome: A Systematic Review
Hanning, N., Edwinson, A. L., Ceuleers, H., Peters, S. A., De Man, J. G., Hassett, L. C., De Winter, B. Y., & Grover, M. (2021) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284821993586 · Cited by 197
Neuroimmunophysiology of the gut: advances and emerging concepts focusing on the epithelium
Sharkey, K. A., Beck, P. L., & McKay, D. M. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0051-4 · Cited by 125
Personality traits and emotional patterns in irritable bowel syndrome
Muscatello, M. R. A., Bruno, A., Mento, C., Pandolfo, G., & Zoccali, R. A. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i28.6402 · Cited by 102
Ali, M. K., & Chen, J. D. Z. (2023) · Diagnostics · doi:10.3390/diagnostics13020293 · Cited by 98
“, 2015 [76] In a two-armed randomized controlled trial Comprehensive self-management (CSM) group (n = 41, age = 40.”
BackgroundResultHealth-Related Quality of Life in Irritable Bowel Syndrome: A Systematic Review and Meta-analysis
Cassar, G. E., Youssef, G. J., Knowles, S. R., Moulding, R., & Austin, D. (2020) · Gastroenterology Nursing · doi:10.1097/sga.0000000000000530 · Cited by 88
Metadata
- Authors
- Jarrett, M. E., Cain, K. C., Barney, P. G., Burr, R. L., Naliboff, B. D., Shulman, R., Zia, J., & Heitkemper, M. M.
- Affiliations
- University of Washington (US)
- University of California, Los Angeles (US)
- Baylor College of Medicine (US)
- Corresponding author
- Heitkemper, Margaret M
- ORCID
- Venue
- Journal of Neurogastroenterology and Motility
- Published
- 2015-12-30
- Volume
- 22
- Issue
- 1
- Pages
- 102-111
- ISSN
- 2093-0879 (ISSN-L)
- 2093-0887
- PMC
- PMC4699727
- OpenAlex
- W2329552564
- Cited by
- 48
- References
- 34
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 4 · 2023: 6 · 2022: 5 · 2021: 3 · 2020: 8 · 2019: 3 · 2018: 5 · 2017: 5 · 2016: 2
- FWCI
- 4.15
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by-nc
- Locations
- Journal of Neurogastroenterology and Motility (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- National Institute of Nursing Research (R01NR004142)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Infant Health and Development
- Keywords
- irritable bowel syndrome, self-management interventions, autonomic nervous system, heart rate variability, vagal modulation, sympathovagal balance, salivary cortisol, IL-10, lactulose/mannitol ratio, treatment response biomarkers, abdominal pain, cognitive behavioral therapy, quality of life, symptom severity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
